Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous platelet-rich plasma versus hyaluronic acid for severe knee osteoarthritis
RBR-10txpdvcNot yet recruiting
- Sponsor
- Instituto Nacional de Traumatologia e Ortopedia Jamil Haddad
- Start
- Nov 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial of platelet-rich plasma and hyaluronic acid in knee osteoarthritis (OA) (3 arms), sponsored by Instituto Nacional de Traumatologia e Ortopedia Jamil Haddad. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
platelet-rich plasmahyaluronic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on RBR-10txpdvc.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-10txpdvc.